Solid Tumors Treatment Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

SOLID TUMORS TREATMENT
MARKET
Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2017–2025
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Solid Tumors Treatment Market Overview
A solid tumor is an abnormal mass or lump of tissues without liquid or cysts. It is not necessary
that tumor should always be cancerous. On the basis tumor nature, it can be classified as the
malignant tumor (cancerous) and the benign tumor (non-cancerous). Based on the cell type,
tumors can be classified as carcinomas, sarcomas, and lymphomas. The Solid tumors might
occur in several places such as muscle, bone, and organs. Treatments for solid tumors include
prevention of tumor and combination of surgery, chemotherapy, and radiation therapy.
However, new forms of treatment are emerging in the market.
Request to view Sample Report: https://www.coherentmarketinsights.com/insight/requestsample/793
Emerging trend of Biosimilars therapy is expected to propel the growth of solid tumors
treatment market
According to data published in International Journal of Pharma Sciences and Research (IJPSR) in
2011, there were around 9 million deaths due to cancer. In 2015, 11.4 million people are
expected to die in 2030, among this prevalence of cancer maximum is due to solid tumors.
Growing prevalence of solid tumors is the major driving factor for the growth of solid tumors
treatment market. Additionally, some other factors fuelling the growth of solid tumors
treatment market include unmet demand for cancer treatment and rising investment in the
research and development of cancer drugs. However, increase in the volume of generic
therapeutic products, the high cost of cancer therapy, and growing drug patent cliff are some of
the restraints that might hinder the growth of solid tumors treatment market.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Chemotherapy segment holds the maximum share in solid tumor treatment market due to its efficacy by
combining with some other therapies to treat solid tumors.
The global solid tumors treatment market is segmented by therapy, by application, by the end user, and by
region.
On the basis of therapy, solid tumors treatment market is segmented into
• Radiotherapy
• Chemotherapy
• Immunotherapy
• Hormone therapy
• Targeted therapy
On the basis of application, solid tumors treatment market is segmented into
• Lung cancer
• Breast cancer
• Prostate cancer
• Cervical cancer
• Colorectal cancer
• others
Request a Customization:
https://www.coherentmarketinsights.com/insight/request-customization/793
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Rising incidences of solid tumor cases in North America is the factor contributing to the growth
of solid tumor treatment market
Regional segmentation of Solid Tumors Treatment market by Coherent Market Insights
comprises of North America, Latin America, Europe, Asia Pacific, Africa, and the Middle East.
North America dominates in the solid tumors treatment market due to the presence of wellestablished healthcare infrastructure, and rise in the number of solid tumor cases. For instance,
According to the data provided by Centers for Disease Control and Prevention (CDC) in 2013
around 230,815 females and 2109 men in the U.S. were diagnosed with breast cancer. Asia
Pacific is expected to grow in the solid tumors market due to the increase in healthcare
expenditure, rising patient population, medical tourism, and increasing affordability of people in
this region.
Get Exclusive Discount on this CMI Report:
https://www.coherentmarketinsights.com/insight/request-discount/793
Advanced drug therapy is expected to help the industry players to sustain in the solid tumors
treatment market
Key industry players operating solid tumors treatment market include Abbott Laboratories Inc.,
Biogen Idec Incorporated, AstraZeneca Plc., Johnson & Johnson Company, Amgen Inc., Bristol Myers
Squibb Company, GlaxoSmithKline Plc., Sanofi, and Baxter International Incorporated.
Advancements in the cancer therapy such as nanomedicines used for the treatment of cancer might
help the industry players to provide effective patient care in the solid tumors treatment. Whereas,
stringent regulatory policies for drug manufacturing may restrain the growth of the market. For
instance, by regulations provided by the Indian government in late 2012, there are cap prices of 348
drugs on Essential Drug List (EDL), and drug manufacturers need to keep the cost of their drugs
below the ceiling price.
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on
assisting its plethora of clients achieve transformational growth by helping them make critical business
decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our
client base includes players from across all business verticals in over 150 countries worldwide. We are
uniquely positioned to help businesses around the globe deliver practical and lasting results through
various recommendations about operational improvements, technologies, emerging market trends and
new working methods. We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We meticulously study
emerging trends across various industries at both the global and regional levels to identify new
opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI
SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry
 Component Providers and System Integrators
 Private and Government organization
 Distributors, Retailors and Value Added Resellers
 Outsourcing Companies
 Healthcare IT Solutions Developers
 Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY
STUDIES
Insights Published
Per Year
GLOBAL
REPORTS
150+
Consulting Projects
Till Date
COUNTRY
ANALYSIS
CONSULT
PROJECTS
125+
Clients Worldwide
Per Year
110+
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals,
including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in
order to result in the best possible market research reports across various industries worldwide. Based on our unmatched
expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better
outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure
sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of
opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
sales@coherentmarketinsights.com
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
sales@coherentmarketinsights.com
+1-206-701-6702
© Coherent market Insights. All Rights Reserved

A solid tumor is an abnormal mass or lump of tissues without liquid or cysts. It is not necessary that tumor should always be cancerous. On the basis tumor nature, it can be classified as the malignant tumor (cancerous) and the benign tumor (non-cancerous). Based on the cell type, tumors can be classified as carcinomas, sarcomas, and lymphomas. The Solid tumors might occur in several places such as muscle, bone, and organs. Treatments for solid tumors include prevention of tumor and combination of surgery, chemotherapy, and radiation therapy. However, new forms of treatment are emerging in the market. Request to view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/793